Global Tubeless Insulin Pumps Market - 2023-2030

Global Tubeless Insulin Pumps Market - 2023-2030

Global tubeless insulin pumps market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.

Tubeless insulin pumps are basically worn as a patch directly on the body and controlled from a wireless handheld device, enabling discreet insulin delivery. The pump does not have a screen and is controlled wirelessly from a touchscreen handheld via Bluetooth. It includes an algorithm placed in a waterproof, closed-loop insulin pump and communicates directly with a continuous glucose monitor for the insulin-releasing process.

Moreover, tubeless insulin pumps can help people with type-1 and type-2 diabetes conveniently to manage their blood sugar levels. These small devices deliver doses of insulin at specific times. The tubeless insulin pumps are a more flexible option than insulin pen injections and other insulin devices. These don’t have to be permanent and can switch to another insulin management method at any time. Tubeless insulin pumps are favorable to the patients, insulin delivery can be done by using wireless devices.

Market Dynamics: Drivers

Increasing advancements in tubeless insulin pumps

The increasing advancements in tubeless pumps are expected to drive the market over the forecast period. The advancements in these pumps are expected to increase the adoption of tubeless insulin pumps. Advancements in tubeless insulin pump technology may result in devices that are smaller, more comfortable, and easier to use. Improvements in user experience can lead to increased patient satisfaction.

For instance, in August 2023, Roche launched its Accu-Chek Solo insulin patch pump and wireless touchscreen handheld device and it has received FDA approval for people with diabetes aged 2 years and older. The system includes a tubeless insulin pump and a wireless handheld controller with Bluetooth, which integrates with blood glucose monitoring and provides bolus advice. This insulin pump system is tubeless, small and lightweight. The device is detachable, allowing people with diabetes to change the infusion site when necessary.

Moreover, if tubeless insulin pumps are designed to integrate seamlessly with CGM systems, allowing for better glucose monitoring and automated insulin adjustments, it can significantly enhance diabetes management. This results in better patient outcomes and further this increases the adoption of advanced devices.

For instance, on June 20, 2023, Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, launched its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes in the United Kingdom. The Omnipod 5 System is where simplicity meets advanced technology. Omnipod 5 is the first CE-marked tubeless hybrid closed loop system that integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System to automatically adjust insulin delivery and help protect against high and low glucose levels.

Furthermore, the incorporation of wireless connectivity and smart features of tubeless insulin pumps can empower users to monitor and control their insulin delivery through digital platforms. This level of connectivity can improve patient convenience. Overall, the advancements in tubeless insulin pumps improve user convenience and further increase adoption.

For instance, on February 14, 2023, EOFlow Co. launched its tubeless, wearable, and disposable insulin pump EOPatch in the UAE. It becomes possible in the UAE to control and manage insulin infusions with EOPatch directly from Android and iOS smartphones using the brand-new Narsha app.

In addition, the increasing prevalence of diabetes, rising regulatory approvals such as FDA approvals, increasing awareness about the advantages of tubeless insulin pumps and technological advancements in the devices are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications and risks associated with tubeless insulin pumps and the high cost of these devices are expected to hamper the market.

Segment Analysis

The global tubeless insulin pumps market is segmented based on type, component, application, distribution channel and region.

The insulin patch pumps segment accounted for approximately 43.2% of the tubeless insulin pumps market share

The insulin patch pumps segment is expected to hold the largest market share over the forecast period. Insulin patch pumps are a type of wearable insulin delivery device that adheres to the skin, typically in the form of a patch. These pumps are designed to provide a continuous delivery of insulin. They offer advantages such as discreetness, ease of use, and reduced interference with daily activities.

Moreover, insulin patch pumps are usually designed to adhere securely to the skin, allowing users to wear them for an extended period without discomfort. For instance, on November 16, 2022, Dexcom U.K. launched a campaign led by four local celebrities who designed their own continuous glucose monitor (CGM) insulin patch pumps to tell their Diabetes Story.

Due to the rising prevalence of diabetes, there is a continuously increasing demand for the use of tubeless insulin pumps. For instance, according to the Centers for Disease Control and Prevention, 2022, there are a total of 37.3 million people have diabetes. These insulin patch pumps are often compact and discreet, making them less noticeable and more convenient for users.

Geographical Analysis

North America accounted for approximately 39.2% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing advancements. North America especially the United States is home to the presence of major players such as medical device companies, which are primarily focussing on the development of tubeless insulin pumps by offering more advanced features to increase patient convenience.

For instance, on April 25, 2023, Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, released the FDA clearance of its latest innovation, Omnipod GO, an insulin delivery device cleared for use for people with type 2 diabetes age 18 or older who would typically take daily injections of long-acting insulin. With its tubeless and waterproof pod, the Omnipod GO provides an alternative to traditional insulin delivery methods.

Furthermore, increasing advancements for tubeless insulin pumps in the region are also expected to drive the market in the region. For instance, on August 11, 2022, EOFlow officially launched its tubeless, wearable, and disposable insulin pump under the diabetes care brand GlucoMen Day PUMP. These advancements increase the adoption of tubeless insulin pumps in the region.

Competitive Landscape

The major global players in the tubeless insulin pumps market include Insulet Corporation, F. Hoffmann-La Roche Ltd, Debiotech SA, CeQur Corporation, Terumo Corporation, Tandem Diabetes Care, Inc., EOFLOW CO., LTD., Medtrum Technologies Inc., Microtec Medical and Ascensia Diabetes Care Holdings AG among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global tubeless insulin pumps market. During the pandemic, the demand for the tubeless insulin pumps has increased. For instance, according to NIH 2020, obesity and diabetes are two major risk factors for COVID‐19 hospitalization. The organization stated that people with diabetes mellitus and severe obesity are more likely to get infected and are at a higher risk of mortality from COVID-19. Among elderly patients who are at higher risk of death from COVID-19, 26.8% have diabetes mellitus, this increased the demand for the adoption of tubeless insulin pumps. However, the pandemic also disrupted the supply chain of these devices globally.

Market Segmentation

By Type
• Insulin Patch Pumps
• Traditional Pumps with Disposable Reservoirs

By Component
• Insulin Pump (Pod)
• Remote Controller

By Application
• Type-1 Diabetes
• Type-2 Diabetes

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?
• To visualize the global tubeless insulin pumps market segmentation based on type, component, application, distribution channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of tubeless insulin pumps market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global tubeless insulin pumps market report would provide approximately 69 tables, 64 figures, and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies